DSFIR — DSM-Firmenich AG Income Statement
0.000.00%
IndustrialsBalancedLarge Cap
- €20.03bn
- €22.54bn
- €12.80bn
Annual income statement for DSM-Firmenich AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 11,444 | 8,390 | 10,627 | 12,799 |
| Cost of Revenue | ||||
| Gross Profit | 4,187 | 2,690 | 2,611 | 4,245 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 10,628 | 7,708 | 11,124 | 12,238 |
| Operating Profit | 816 | 682 | -497 | 561 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 645 | 594 | -647 | 427 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 530 | 470 | -629 | 280 |
| Minority Interest | ||||
| Equity in Affiliates | ||||
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | 872 | 1,700 | 2,137 | 250 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 872 | 1,694 | 2,131 | 250 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 5.99 | 3.43 | -0.193 | 1.75 |
| Dividends per Share |